Inventor

HILLISCH ALEXANDER

DE41 patents

⚠️ This page may combine multiple inventors who share the name “HILLISCH ALEXANDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HILLISCH ALEXANDER

Bayer Pharma AG

Substituted oxopyridine derivatives and use thereof cardiovascular disorders

Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders

Substituted oxopyridine derivatives and use thereof as factor xia/plasma

Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders

Substituted oxopyridine derivatives and use thereof as factor XIa/plasma

Substituted oxopyridine derivatives

Substituted oxopyridine derivatives

Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives

Substituted oxopyridine derivatives

Substituted oxopyridine derivatives

Substituted oxopyridine derivatives

Substituted oxopyridine derivatives

Substituted oxopyridine derivatives

Substituted benzoxazoles

SCHERING AG

18 Norsteroids as selectively active estrogens

9-α-substituted estratrienes as selectively active estrogens

8β-hydrocarbyl-substituted estratrienes for use as selective estrogens

11β-Substituted 19-nor-17-α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ring

2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1

Compounds with sulphonamide group and pharmaceutical compositions containing these compounds

11β-long-chain-substituted 19-nor-17α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ring

17α-fluorosteroids, pharmaceutical compositions containing 17α-fluorosteroids and a method of making them

Methylene-4-azasteroids

2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1

8β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes

BAYER SCHERING PHARMA AG

Estradiol prodrugs

Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy

Glucocorticoid receptor antagonists for prophylaxis and therapy of glucocorticoid-mediated hypogonadism, of sexual dysfunction and/or infertility

2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1

STERIX LTD

2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action

Antitumoral D-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates

Antitumoral d-homoestra-1,3,5 (10)-trien-3-yl 2-substituted sulfamates

Antitumor-active 2-alkoxyestradiol sulfamates

LAMPE THOMAS

Acyclically substituted furopyrimidine derivatives and use thereof

Cyclically substituted furopyrimidine derivatives and use thereof

BAYER HEALTHCARE LLC

Pyrimidine derivatives for treatment of hyperproliferative disorders

BAYER PHARMACEUTICALS CORP

Pyrimidine derivatives for treatment of hyperproliferative disorders

BAYER AG

Substituted S-alaninate derivatives

JENAPHARM GMBH

17-Methylene steroids, process for their production and pharmaceutical compositions that contain these compounds

HILLISCH ALEXANDER

2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumor action

KOLKHOF PETER

Substituted 7-sulfanylmethyl-, 7-sulfinylmethyl- and 7-sulfonylmethylindoles and the use thereof